Brought to you by 
Abbott licenses Rubicon's Guardian; gives rights back
03 Jan 2003
Executive Summary
Abbott Laboratories licensed exclusive global rights to Rubicon Medical's Guardian occlusion balloon for embolization protection.
Deal Industry
-
Medical Devices
- Implantable Devices
- Surgical Equipment & Devices
Deal Status
- Terminated
Deal Type
-
Alliance
- Includes Contract
- Includes Royalty or Profit Split Information
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Abbott licenses Rubicon's Guardian; gives rights back
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice